Padcev/Keytruda scores again in early bladder cancer
Автор: pharmaphorum media limited
Загружено: 2025-12-17
Просмотров: 175
Описание:
🎙️ In today’s news: 17th December
Pfizer and Astellas now have two studies supporting the use of Padcev with MSD's Keytruda as perioperative therapy for muscle-invasive bladder cancer.
Shares in DBV have shot up on phase 3 results that set up a US filing for its peanut allergy therapy. which could plug a looming hole in the market.
LIB Therapeutics has won FDA approval for a once-monthly cholesterol drug, Lerochol, that it says offers ease-of-use advantages over rivals.
GSK scores a first approval in the UK for new severe asthma and CRSwNP therapy Exdensur, but a second in the US covers the asthma indication only.
Overturning decades of advice, the CDC has said it no longer recommends that all US newborns receive a hepatitis B vaccine.
Subscribe to @Pharmaphorum daily news updates and check out www.pharmaphorum.com for more insights and analysis.
#pharmanews #pharma #pharmaindustry #newsoftheday #lifesciences #news #pfizer #astellas #keytruda #msd #padcev #bladdercancer #dbv #peanutallergy #fdaapproval #cholesterol #gsk #asthmamanagement #cdc #hepatitisbvaccine
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
